Free Access
Editorial
| Issue |
Med Sci (Paris)
Volume 30, Novembre 2014
2e colloque de l’ITMO Santé publique – Médecine « personnalisée » et innovations biomédicales : enjeux de santé publique, économiques, éthiques et sociaux (Paris, 5 décembre 2013)
|
|
|---|---|---|
| Page(s) | 4 - 7 | |
| Section | Éditorial | |
| DOI | https://doi.org/10.1051/medsci/201430s201 | |
| Published online | 17 November 2014 | |
- Hansen AH. Full recovery or stagnation? New York : W.W. Norton Eds, 1938. [Google Scholar]
- Summers LH. US economic prospects: secular stagnation, hysteresis, and the zero lower lound. Business Economics 2014 ; 49 : 65–73. [CrossRef] [Google Scholar]
- Teulings C, Baldwin R (Eds). Secular stagnation: facts, causes and cures London : CPER Press, A Vox EU.org book, 2014. [Google Scholar]
- Gordon RJ. The demise of US economic growth: restatement, rebuttal, and reflections. Boston: National Bureau of Economic Research, Working paper n° 19895, February 2014. [Google Scholar]
- Vijg J., The American technological challenge: stagnation and decline in the 21st century. New York : Algora Pub, 2011. [Google Scholar]
- Bloom N, Romer PM, Terry SJ, Reenen JV. A trapped factors model of innovation. Am Eco Rev 2013 ; 103 : 208–213. [CrossRef] [Google Scholar]
- Brynjolfsson E, Mcafee A. The second machine age: work, progress, and prosperity in a time of brilliant technologies. New York : W.W. Norton Eds, 2014. [Google Scholar]
- OCDE. Nouvelles sources de croissance : le capital intellectuel. Paris : OCDE Éditions, 2013. [Google Scholar]
- European Science Foundation. Personalized medicine for the European citizen. www.esf.org, Strasbourg, novembre 2012. [Google Scholar]
- Commission Open Data en Santé. Rapport à la Ministre des Affaires Sociales et de la Santé, 9 juillet 2014. http://www.drees.sante.gouv.fr/rapport-de-la-commission-open-data-en-sante,11323.html. [Google Scholar]
- http://www.mammaprint.fr/ [Google Scholar]
- President’s Council of Advisors on Science and Technology. Priorities for personalized medicine. Washington DC: White House, September 2008. http://www.whitehouse.gov/files/documents/ostp/PCAST/pcast_report_v2.pdf. [Google Scholar]
- Hingorani AD, Windt DA, Riley RD. Prognosis research strategy (PROGRESS) 4 : stratified medicine research. Br Med J 2013 ; 346 : e5793. [CrossRef] [PubMed] [Google Scholar]
- Chakravarti A. Genomics is not enough. Science 2011 ; 334 : 315. [CrossRef] [PubMed] [Google Scholar]
- Thiebaut R, Hejblum B, Richert L. The analysis of Big Data in clinical research. Rev Epidemiol Sante Publ 2014 ; 62 : 1–4. [CrossRef] [Google Scholar]
- http://www.agence-nationale-recherche.fr/fileadmin/aap/2015/pa-anr-2015-aap-generique.pdf. [Google Scholar]
- Ginsburg GS, Haga SB. Translating genomic biomarkers into clinically useful diagnostics. Expert Rev Mol Diagn 2006 ; 6 : 179–191. [CrossRef] [PubMed] [Google Scholar]
- Sarradon-Eck A, Sakoyan J, Desclaux A, et al. They should take time: disclosure of clinical trial results as part of a social relationship. Soc Sci Med 2012 ; 75 : 873–882. [CrossRef] [PubMed] [Google Scholar]
- Hatz MHM, Schremser K, Rogowski WH. Is individualized medicine more cost-effective? A systematic review. PharmacoEconomics 2014 ; 32 : 443–455. [CrossRef] [PubMed] [Google Scholar]
- Gadrey J, Jany-Catrice F. Les nouveaux indicateurs de richesse. Paris : La Découverte, 2012. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.